肠必克联合柳氮磺吡啶治疗溃疡性结肠炎56例疗效分析

Therapeutic Effect of the Combined Medication of Changbike and Salicylazosulfapyridine in the Treatment of Ulcerative Colitis

为探讨溃疡性结肠炎的有效治疗方法，采用中成药肠必克和柳氮磺吡啶合用治疗溃疡性结肠炎56例，与单用柳氮磺吡啶组进行疗效比较。治疗组56例，有效率100％，治愈43例，治愈率76．8％，6个月后复发4例，复发率7．1％。对照组40例，有效26例，有效率65％，治愈15例，治愈率37．5％，6个月后复发9例，复发率34．6％。两组有效率、治愈率、复发率差别均有统计学意义。结果表明，肠必克和柳氮磺吡啶合用治疗溃疡性结肠炎疗效非常显著。

The objective of the study was to probe into a more effective therapy in the treatment of ulcerative colitis. Combined medication of CBK（traditional Chinese drug） and salicylazosulfapyridine（SASP） was applied in 56 patients and was controlled with SASP treatment. As results, the cure rate of the CBK＋SASP treatment group was 76.8% （43/56）,the effective rate was 100%,recurrence occurred in 4 cases（7.1%, 4/56） 6 monthes after combined treatment. While in the controlled group, cure was achieved in 15 cases （37.5%, 15/40） ,the effective rate was 65.0%（26/40） ,and recurrence occurred in 9 cases （34. 6% ,9/40） 6 monthes after SASP treatment. There was statistical significance in effective rate, cure rate and recurrence rate between the two groups. It is concluded that the therapeutic effect of combined medication of CBK plus SASP in the treatment of ulcerative colitis is prominent.